Impact of the COVID-19 Pandemic on Vaccination

Completed

• Conditions: Covid19
• Interventions: Other: Vaccine coverage assessment

• Registration Number: NCT04657263
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

The vaccination policy is drawn up in France by the French Minister of Health, who makes public the vaccination schedule after the opinion of the High Authority of Health.

Currently according to the 2019 immunization schedule, the dTP vaccine is the only mandatory in the general population with recalls in adults aged 25, 45, 65 and every 10 years. In 2011, the Ministry of Health estimated that only 50.5% of the general population was up to date against dTP.

Two vaccines are recommended for person at risk of infection according to the current vaccine schedule: the flu vaccine and the pneumococcal vaccine. In fact, influenza and pneumococcal disease are more frequent and more serious in patients with chronic diseases (diabetes, cardiac insufficiency..) compared to the general population.

The vaccination coverage rate of at-risk populations is dramatically below the vaccination coverage targets set by the Ministry of Health. Indeed, there are many barriers to vaccination, medical and para-medical barriers, but also individual barriers.

The current COVID-19 pandemic has identified people at risk of severe infection and death risk, particularly those with co-morbidities (diabetes, cardiovascular disease, etc.). Thus, this pandemic may have contributed to change in patients' perceptions regarding both the risk of infection and the potential interest and benefit of vaccination.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-01
• Study First Submitted: 2020-12-07
• Study First Submitted QC: 2020-12-07
• Study First Posted: 2020-12-08
• Primary Completion: 2021-05-01
• Study Completion: 2021-05-30
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-22
• Last Update Posted: 2021-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Person at risk of infection according to French 2019 immunization	Vaccine coverage assessment	Person at risk of infection according to French 2019 immunization

Primary Outcome Measures

Name	Time	Method
number of persons at risk of infection up to date with their mandatory and recommended vaccinations during COVID19 pandemic	1 day	number of persons at risk of infection up to date with their mandatory and recommended vaccinations during COVID19 pandemic

Secondary Outcome Measures

Name	Time	Method
Number of persons at risk of infection accepting COVID19 vaccination	1 day	Number of persons at risk of infection accepting COVID19 vaccination

Trial Locations

Locations (1)

Uhmontpellier; 🇫🇷 Montpellier, France